Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prognostic performance of the 1973 and 2004 WHO grading classification in upper tract urothelial carcinoma.

Guan B, Tang S, Zhan Y, Li Y, Fang D, Peng D, Gong Y, He S, Zhang L, Yang K, Xiong G, Liu L, He Q, Li X, Zhou L.

Urol Oncol. 2019 May 30. pii: S1078-1439(19)30014-6. doi: 10.1016/j.urolonc.2019.01.013. [Epub ahead of print]

PMID:
31153747
2.

Variant histology as a significant predictor of survival after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Kim JK, Moon KC, Jeong CW, Kwak C, Kim HH, Ku JH.

Urol Oncol. 2017 Jul;35(7):458.e9-458.e15. doi: 10.1016/j.urolonc.2017.02.010. Epub 2017 Mar 24.

PMID:
28347659
3.

Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.

Grasso M, Fishman AI, Cohen J, Alexander B.

BJU Int. 2012 Dec;110(11):1618-26. doi: 10.1111/j.1464-410X.2012.11066.x. Epub 2012 Mar 28.

4.

Histopathologic Characteristics of Upper Tract Urothelial Carcinoma With an Emphasis on Their Effect on Cancer Survival: A Single-Institute Experience With 305 Patients With Long-Term Follow-Up.

Elawdy MM, Taha DE, Elbaset MA, Abouelkheir RT, Osman Y.

Clin Genitourin Cancer. 2016 Dec;14(6):e609-e615. doi: 10.1016/j.clgc.2016.04.017. Epub 2016 May 5.

PMID:
27262370
5.

Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.

Shibing Y, Turun S, Qiang W, Junhao L, Haichao Y, Shengqiang Q, Ping H, Dehong C.

Urol Oncol. 2015 May;33(5):204.e9-16. doi: 10.1016/j.urolonc.2015.02.010. Epub 2015 Mar 20.

PMID:
25800374
6.

Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis.

Tian Y, Gong Y, Pang Y, Wang Z, Hong M.

PeerJ. 2016 Jun 21;4:e2144. doi: 10.7717/peerj.2144. eCollection 2016.

7.

Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma.

Singla N, Krabbe LM, Aydin AM, Panwar V, Woldu SL, Freifeld Y, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Bagrodia A, Kapur P, Margulis V.

Urol Oncol. 2018 Jul;36(7):343.e1-343.e8. doi: 10.1016/j.urolonc.2018.04.004. Epub 2018 May 7.

PMID:
29748098
8.

Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?

Tan P, Chen J, Xie N, Xu H, Ai J, Xu H, Liu L, Yang L, Wei Q.

Cancer Med. 2018 Oct;7(10):5096-5106. doi: 10.1002/cam4.1751. Epub 2018 Aug 27.

9.

Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.

Kim HS, Ku JH, Jeong CW, Kwak C, Kim HH.

World J Urol. 2016 Jun;34(6):859-69. doi: 10.1007/s00345-015-1712-3. Epub 2015 Oct 23.

PMID:
26497823
10.

Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.

Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.

Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004. Epub 2012 Apr 21.

PMID:
22521771
11.

Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.

Qin C, Liang EL, Du ZY, Qiu XY, Tang G, Chen FR, Zhang B, Tian DW, Hu HL, Wu CL.

Medicine (Baltimore). 2017 May;96(21):e6945. doi: 10.1097/MD.0000000000006945.

12.

TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma.

Youssef RF, Krabbe LM, Shariat SF, Lotan Y, Sagalowsky AI, Raman J, Wood CG, Weizer A, Roscigno M, Montorsi F, Bolenz C, Remzi M, Bensalah K, Kassouf W, Margulis V.

World J Urol. 2015 Dec;33(12):1965-72. doi: 10.1007/s00345-015-1566-8. Epub 2015 May 10.

PMID:
25957592
13.

High aspartate transaminase/alanine transaminase ratio predicts poor prognosis in patients with localized upper tract urothelial cancer: a propensity score-matched study in a large Chinese center.

Li Y, Fang D, Bao Z, He A, Guan B, He S, Zhan Y, Gong Y, Li X, Zhou L.

Onco Targets Ther. 2019 Apr 11;12:2635-2648. doi: 10.2147/OTT.S193771. eCollection 2019.

14.

Impact of AIB1 expression on the prognosis of upper tract urothelial carcinoma after radical nephroureterectomy.

Huang Y, Cen J, Wei J, Chen Z, Fang Y, Feng Z, Lu J, Liang Y, Luo J, Mo C, Chen W.

Cancer Biomark. 2019;25(2):151-160. doi: 10.3233/CBM-182020.

PMID:
31045512
16.

High postoperative neutrophil-to-lymphocyte ratio as a poor prognostic marker in patients with upper tract urothelial carcinoma.

Nishihara K, Suekane S, Ueda K, Nakiri M, Matsuo M, Igawa T.

Oncol Lett. 2019 Jun;17(6):5241-5250. doi: 10.3892/ol.2019.10178. Epub 2019 Mar 21.

17.

The prognostic significance of Albumin-to-Alkaline Phosphatase Ratio in upper tract urothelial carcinoma.

Tan P, Xie N, Ai J, Xu H, Xu H, Liu L, Yang L, Wei Q.

Sci Rep. 2018 Aug 17;8(1):12311. doi: 10.1038/s41598-018-29833-5.

18.

Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.

Cutress ML, Stewart GD, Wells-Cole S, Phipps S, Thomas BG, Tolley DA.

BJU Int. 2012 Dec;110(11):1608-17. doi: 10.1111/j.1464-410X.2012.11169.x. Epub 2012 May 7.

19.

Prognostic impact of preoperative anemia on upper tract urothelial carcinoma.

Tan P, Xie N, Liao H, Zou L, Xu H, Yang L, Liu L, Wei Q.

Medicine (Baltimore). 2018 Sep;97(37):e12300. doi: 10.1097/MD.0000000000012300.

20.

Gender Is a Significant Prognostic Factor for Upper Tract Urothelial Carcinoma: A Large Hospital-Based Cancer Registry Study in an Endemic Area.

Huang CC, Su YL, Luo HL, Chen YT, Sio TT, Hsu HC, Lai CH.

Front Oncol. 2019 Mar 21;9:157. doi: 10.3389/fonc.2019.00157. eCollection 2019.

Supplemental Content

Support Center